Breast cancer
Systemic therapy for HER2-positive early breast cancerBarbara (68 years old)
Barbara is a 68-year-old retired high school teacher who loves to go for long hikes in her newly gained free time. Unfortunately, she was diagnosed with HER2-positive breast cancer.
Assessment summary
- Postmenopausal
- Medical history: surgical repair torn cruciate ligament
- ECOG PS: 0
- Initial tumour size: cT2 (38 mm), initial lymph node status: cN1
- Tumour biology: ER 0%, PgR 0%, HER2 IHC 3+, G3
- CT scan chest/abdomen and bone scan: no metastases
- Neoadjuvant therapy: anthracycline/taxane + trastuzumab + pertuzumab
- Surgical therapy: breast conserving surgery and SLNB
- Pathology report: residual invasive disease: ypT1c (12 mm), ypN0 (0/3 sn)
- Adjuvant therapy: regimen of anti-HER2 therapy + radiation therapy